Clinical Trials Directory

Trials / Unknown

UnknownNCT01786057

Effect of Extracorporeal Shock Wave Therapy of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis

The Effect of Extracorporeal Shock Wave Therapy (ESWT)of Gastrosoleus Trigger Points in Patients With Plantar Fasciitis

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
48 (estimated)
Sponsor
Isfahan University of Medical Sciences · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Plantar fasciitis is one of the most common causes of heel pain. This study will be performed in the purpose of determination the effects of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Detailed description

Plantar fasciitis is the most common cause of inferior heel pain, A great variety of therapies have been reported for the treatment of plantar fasciitis including extracorporeal shock wave therapy. Gastrosoleus muscle dysfunction is one of the most common contributing factors to this disease .Despite the long history and the fact that this is a common diagnosis made in clinical practice, the exact cause and best treatment for this condition still are being explored. Although there is lack of high-quality studies demonstrating the efficacy of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis , this study will be performed to examine the effect of extracorporeal shock wave therapy of gastrosoleus trigger points in patients with plantar fasciitis

Conditions

Interventions

TypeNameDescription
PROCEDUREExtracorporeal shock wave therapy 1Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region and (400 shock waves/session of 0.2 mJ/mm2 per each trigger point) for gastrosoleus trigger points , 3 sessions at weekly intervals
PROCEDUREExtracorporeal shock wave therapy 2Extracorporeal shock wave therapy , (3000 shock waves/session of 0.2 mJ/mm2) for heel region , 3 sessions at weekly intervals

Timeline

Start date
2012-11-01
Primary completion
2013-08-01
Completion
2013-10-01
First posted
2013-02-07
Last updated
2013-02-07

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT01786057. Inclusion in this directory is not an endorsement.